FDG-PET response predicts overall and disease free survival after induction chemotherapy of locally advanced (stage III) Non-Small Cell Lung Cancer (NSCLC)

B. Danner, T. Overbeck, H. Schmidberger, B. Hemmerlein, F. Schöndube & F. Griesinger
Introduction: Pathologic response after induction therapy has shown to have a major impact on outcome. The non-invasive FDG-PET could predict tumor response in NSCLC (non-small cell lung cancer) and is a possible tool to identify potential candidates for cure in advanced NSCLC IIIA/IIIB after induction[for full text, please go to the a.m. URL]